Results 261 to 270 of about 154,358 (318)

Percutaneous epicardial access for mapping and ablation of cardiac arrhythmias: a procedure in need of innovation. [PDF]

Europace
Santangeli P, Di Biase L, Natale A.
europepmc   +1 more source

Hypertrophic cardiomyopathy combined with renal and adrenal aplasia in a male with Noonan syndrome from RAF1 variant

ESC Heart Failure, EarlyView.
Ying Wang, Guizhou Ma, Dianyu Cai, Jierong Yao, Bingying Huang, Chaojian Wu, Xiaoling Liu, Zhixiong Cai   +7 more
wiley   +1 more source

Early occurrence of heart failure hospitalization or ventricular arrhythmia re‐define the long‐term prognosis after CRT

ESC Heart Failure, EarlyView.
Abstract Aims Classifying patients as responders or non‐responders to cardiac resynchronization therapy (CRT) has been recently challenged, suggesting that preventing heart failure (HF) progression may also provide survival benefits. We assessed a novel classification based on echocardiographic left ventricular (LV) reverse remodelling and the ...
Anna Zsofia Toth, Laszlo Nagy, Krisztina Maria Szabo, Vivien Racz, Alexandra Kiss, Gabor Sandorfi, Attila Borbely, Tibor Laszlo Nagy, Zoltan Csanadi   +8 more
wiley   +1 more source

Risk of Cardiac Arrhythmias Among Climbers on Mount Everest.

JAMA Cardiol
Sherpa K, Sherpa PP, Sherpa T, Rothenbühler M, Ryffel C, Sherpa D, Sherpa DR, Sherchand O, Galuszka O, Dernektsi C, Reichlin T, Pilgrim T.   +11 more
europepmc   +1 more source

T1 mapping and major cardiovascular events in non‐ischaemic dilated cardiomyopathy: a systematic review and meta‐analysis

ESC Heart Failure, EarlyView.
In NIDCM patients, native T1 mapping and ECV were associated with increased risk of the composite primary endpoint of MACE and the secondary endpoint of heart failure and arrhythmic‐related events. Patients who experienced MACE had higher values of both T1 mapping and ECV.
Federico Marchini, Beatrice Dal Passo, Gianluca Campo, Elisabetta Tonet, Matteo Serenelli, Alberto Cossu, Serena Chiarello, Maria Lo Monaco, Erika Bertella, Rita Pavasini   +9 more
wiley   +1 more source

Prescription of guideline‐directed medical therapy in heart failure: impact on mortality and readmission

ESC Heart Failure, EarlyView.
Routine data analysis showing a better outcome regarding mortality and readmission in HF patients when being prescribed the current four‐drug treatment (vs. the outdated two‐drug therapy) 91–365 days after index hospital stay. Abstract Aims The 2021 European heart failure (HF) guidelines recommend the combination of four drugs as a standard therapy ...
Martin Möckel, Samipa Pudasaini, Kristina Feldmann, Henning Thomas Baberg, Benny Levenson, Jürgen Malzahn, Thomas Mansky, Guido Michels, Christian Günster, Elke Jeschke   +9 more
wiley   +1 more source

Immune Checkpoint Inhibitors and Cardiovascular Adverse Events

ESC Heart Failure, EarlyView.
Abstract In the last years, we assisted to a tremendous increase in therapeutic options for the management of cancers, with immunotherapy at the forefront of this innovation. Immune checkpoint inhibitors (ICIs) have been developed to enhance the activity of the immune system against cancer cells (1) and the number of approvals for ICIs has rapidly ...
Maria Luisa De Perna, Elia Rigamonti, Raffaele Zannoni, Vittoria Espeli, Giorgio Moschovitis   +4 more
wiley   +1 more source

Implications for neutrophils in cardiac arrhythmias.

Am J Physiol Heart Circ Physiol
Hegemann N, Barth L, Döring Y, Voigt N, Grune J.   +4 more
europepmc   +1 more source

The adipose-neural axis is involved in epicardial adipose tissue-related cardiac arrhythmias. [PDF]

Cell Rep Med
Fan Y, Huang S, Li S, Wu B, Zhao Q, Huang L, Zheng Z, Xie X, Liu J, Huang W, Sun J, Zhu X, Zhu J, Xiang AP, Li W.   +14 more
europepmc   +1 more source

Delayed cardiac consequences unveiled by magnetic resonance imaging in a high‐voltage electric shock survivor

ESC Heart Failure, EarlyView.
Golnaz Houshmand, Majid Sadeghpour, Faezeh Tabesh   +2 more
wiley   +1 more source